Global Enzalutamide API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.
LPI (LP Information)' newest research report, the “Enzalutamide API Industry Forecast” looks at past sales and reviews total world Enzalutamide API sales in 2022, providing a comprehensive analysis by region and market sector of projected Enzalutamide API sales for 2023 through 2029. With Enzalutamide API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzalutamide API industry.
This Insight Report provides a comprehensive analysis of the global Enzalutamide API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzalutamide API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Enzalutamide API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzalutamide API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzalutamide API.
The global Enzalutamide API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Enzalutamide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Enzalutamide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Enzalutamide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Enzalutamide API players cover Dr. Reddy’s Laboratories Ltd., Shilpa Medicare Limited, ScinoPharm Taiwan, Ltd, Olon Spa, Farmhispania, S.A., Mac-Chem Products (India) Pvt.Ltd and Shandong Haohong Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzalutamide API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Enzalutamide API market?
What factors are driving Enzalutamide API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enzalutamide API market opportunities vary by end market size?
How does Enzalutamide API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.
LPI (LP Information)' newest research report, the “Enzalutamide API Industry Forecast” looks at past sales and reviews total world Enzalutamide API sales in 2022, providing a comprehensive analysis by region and market sector of projected Enzalutamide API sales for 2023 through 2029. With Enzalutamide API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enzalutamide API industry.
This Insight Report provides a comprehensive analysis of the global Enzalutamide API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enzalutamide API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Enzalutamide API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enzalutamide API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enzalutamide API.
The global Enzalutamide API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Enzalutamide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Enzalutamide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Enzalutamide API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Enzalutamide API players cover Dr. Reddy’s Laboratories Ltd., Shilpa Medicare Limited, ScinoPharm Taiwan, Ltd, Olon Spa, Farmhispania, S.A., Mac-Chem Products (India) Pvt.Ltd and Shandong Haohong Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Enzalutamide API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Purity?98%
- Purity<98%
- Enzalutamide Capsules
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dr. Reddy’s Laboratories Ltd.
- Shilpa Medicare Limited
- ScinoPharm Taiwan, Ltd
- Olon Spa
- Farmhispania, S.A.
- Mac-Chem Products (India) Pvt.Ltd
- Shandong Haohong Biotechnology
What is the 10-year outlook for the global Enzalutamide API market?
What factors are driving Enzalutamide API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enzalutamide API market opportunities vary by end market size?
How does Enzalutamide API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enzalutamide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Enzalutamide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Enzalutamide API by Country/Region, 2018, 2022 & 2029
2.2 Enzalutamide API Segment by Type
2.2.1 Purity?98%
2.2.2 Purity<98%
2.3 Enzalutamide API Sales by Type
2.3.1 Global Enzalutamide API Sales Market Share by Type (2018-2023)
2.3.2 Global Enzalutamide API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Enzalutamide API Sale Price by Type (2018-2023)
2.4 Enzalutamide API Segment by Application
2.4.1 Enzalutamide Capsules
2.4.2 Others
2.5 Enzalutamide API Sales by Application
2.5.1 Global Enzalutamide API Sale Market Share by Application (2018-2023)
2.5.2 Global Enzalutamide API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Enzalutamide API Sale Price by Application (2018-2023)
3 GLOBAL ENZALUTAMIDE API BY COMPANY
3.1 Global Enzalutamide API Breakdown Data by Company
3.1.1 Global Enzalutamide API Annual Sales by Company (2018-2023)
3.1.2 Global Enzalutamide API Sales Market Share by Company (2018-2023)
3.2 Global Enzalutamide API Annual Revenue by Company (2018-2023)
3.2.1 Global Enzalutamide API Revenue by Company (2018-2023)
3.2.2 Global Enzalutamide API Revenue Market Share by Company (2018-2023)
3.3 Global Enzalutamide API Sale Price by Company
3.4 Key Manufacturers Enzalutamide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enzalutamide API Product Location Distribution
3.4.2 Players Enzalutamide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ENZALUTAMIDE API BY GEOGRAPHIC REGION
4.1 World Historic Enzalutamide API Market Size by Geographic Region (2018-2023)
4.1.1 Global Enzalutamide API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Enzalutamide API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Enzalutamide API Market Size by Country/Region (2018-2023)
4.2.1 Global Enzalutamide API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Enzalutamide API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Enzalutamide API Sales Growth
4.4 APAC Enzalutamide API Sales Growth
4.5 Europe Enzalutamide API Sales Growth
4.6 Middle East & Africa Enzalutamide API Sales Growth
5 AMERICAS
5.1 Americas Enzalutamide API Sales by Country
5.1.1 Americas Enzalutamide API Sales by Country (2018-2023)
5.1.2 Americas Enzalutamide API Revenue by Country (2018-2023)
5.2 Americas Enzalutamide API Sales by Type
5.3 Americas Enzalutamide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enzalutamide API Sales by Region
6.1.1 APAC Enzalutamide API Sales by Region (2018-2023)
6.1.2 APAC Enzalutamide API Revenue by Region (2018-2023)
6.2 APAC Enzalutamide API Sales by Type
6.3 APAC Enzalutamide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enzalutamide API by Country
7.1.1 Europe Enzalutamide API Sales by Country (2018-2023)
7.1.2 Europe Enzalutamide API Revenue by Country (2018-2023)
7.2 Europe Enzalutamide API Sales by Type
7.3 Europe Enzalutamide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enzalutamide API by Country
8.1.1 Middle East & Africa Enzalutamide API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Enzalutamide API Revenue by Country (2018-2023)
8.2 Middle East & Africa Enzalutamide API Sales by Type
8.3 Middle East & Africa Enzalutamide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enzalutamide API
10.3 Manufacturing Process Analysis of Enzalutamide API
10.4 Industry Chain Structure of Enzalutamide API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enzalutamide API Distributors
11.3 Enzalutamide API Customer
12 WORLD FORECAST REVIEW FOR ENZALUTAMIDE API BY GEOGRAPHIC REGION
12.1 Global Enzalutamide API Market Size Forecast by Region
12.1.1 Global Enzalutamide API Forecast by Region (2024-2029)
12.1.2 Global Enzalutamide API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enzalutamide API Forecast by Type
12.7 Global Enzalutamide API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy’s Laboratories Ltd.
13.1.1 Dr. Reddy’s Laboratories Ltd. Company Information
13.1.2 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product Portfolios and Specifications
13.1.3 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dr. Reddy’s Laboratories Ltd. Main Business Overview
13.1.5 Dr. Reddy’s Laboratories Ltd. Latest Developments
13.2 Shilpa Medicare Limited
13.2.1 Shilpa Medicare Limited Company Information
13.2.2 Shilpa Medicare Limited Enzalutamide API Product Portfolios and Specifications
13.2.3 Shilpa Medicare Limited Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shilpa Medicare Limited Main Business Overview
13.2.5 Shilpa Medicare Limited Latest Developments
13.3 ScinoPharm Taiwan, Ltd
13.3.1 ScinoPharm Taiwan, Ltd Company Information
13.3.2 ScinoPharm Taiwan, Ltd Enzalutamide API Product Portfolios and Specifications
13.3.3 ScinoPharm Taiwan, Ltd Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ScinoPharm Taiwan, Ltd Main Business Overview
13.3.5 ScinoPharm Taiwan, Ltd Latest Developments
13.4 Olon Spa
13.4.1 Olon Spa Company Information
13.4.2 Olon Spa Enzalutamide API Product Portfolios and Specifications
13.4.3 Olon Spa Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Olon Spa Main Business Overview
13.4.5 Olon Spa Latest Developments
13.5 Farmhispania, S.A.
13.5.1 Farmhispania, S.A. Company Information
13.5.2 Farmhispania, S.A. Enzalutamide API Product Portfolios and Specifications
13.5.3 Farmhispania, S.A. Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Farmhispania, S.A. Main Business Overview
13.5.5 Farmhispania, S.A. Latest Developments
13.6 Mac-Chem Products (India) Pvt.Ltd
13.6.1 Mac-Chem Products (India) Pvt.Ltd Company Information
13.6.2 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product Portfolios and Specifications
13.6.3 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mac-Chem Products (India) Pvt.Ltd Main Business Overview
13.6.5 Mac-Chem Products (India) Pvt.Ltd Latest Developments
13.7 Shandong Haohong Biotechnology
13.7.1 Shandong Haohong Biotechnology Company Information
13.7.2 Shandong Haohong Biotechnology Enzalutamide API Product Portfolios and Specifications
13.7.3 Shandong Haohong Biotechnology Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shandong Haohong Biotechnology Main Business Overview
13.7.5 Shandong Haohong Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Enzalutamide API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Enzalutamide API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Enzalutamide API by Country/Region, 2018, 2022 & 2029
2.2 Enzalutamide API Segment by Type
2.2.1 Purity?98%
2.2.2 Purity<98%
2.3 Enzalutamide API Sales by Type
2.3.1 Global Enzalutamide API Sales Market Share by Type (2018-2023)
2.3.2 Global Enzalutamide API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Enzalutamide API Sale Price by Type (2018-2023)
2.4 Enzalutamide API Segment by Application
2.4.1 Enzalutamide Capsules
2.4.2 Others
2.5 Enzalutamide API Sales by Application
2.5.1 Global Enzalutamide API Sale Market Share by Application (2018-2023)
2.5.2 Global Enzalutamide API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Enzalutamide API Sale Price by Application (2018-2023)
3 GLOBAL ENZALUTAMIDE API BY COMPANY
3.1 Global Enzalutamide API Breakdown Data by Company
3.1.1 Global Enzalutamide API Annual Sales by Company (2018-2023)
3.1.2 Global Enzalutamide API Sales Market Share by Company (2018-2023)
3.2 Global Enzalutamide API Annual Revenue by Company (2018-2023)
3.2.1 Global Enzalutamide API Revenue by Company (2018-2023)
3.2.2 Global Enzalutamide API Revenue Market Share by Company (2018-2023)
3.3 Global Enzalutamide API Sale Price by Company
3.4 Key Manufacturers Enzalutamide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enzalutamide API Product Location Distribution
3.4.2 Players Enzalutamide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ENZALUTAMIDE API BY GEOGRAPHIC REGION
4.1 World Historic Enzalutamide API Market Size by Geographic Region (2018-2023)
4.1.1 Global Enzalutamide API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Enzalutamide API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Enzalutamide API Market Size by Country/Region (2018-2023)
4.2.1 Global Enzalutamide API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Enzalutamide API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Enzalutamide API Sales Growth
4.4 APAC Enzalutamide API Sales Growth
4.5 Europe Enzalutamide API Sales Growth
4.6 Middle East & Africa Enzalutamide API Sales Growth
5 AMERICAS
5.1 Americas Enzalutamide API Sales by Country
5.1.1 Americas Enzalutamide API Sales by Country (2018-2023)
5.1.2 Americas Enzalutamide API Revenue by Country (2018-2023)
5.2 Americas Enzalutamide API Sales by Type
5.3 Americas Enzalutamide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enzalutamide API Sales by Region
6.1.1 APAC Enzalutamide API Sales by Region (2018-2023)
6.1.2 APAC Enzalutamide API Revenue by Region (2018-2023)
6.2 APAC Enzalutamide API Sales by Type
6.3 APAC Enzalutamide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Enzalutamide API by Country
7.1.1 Europe Enzalutamide API Sales by Country (2018-2023)
7.1.2 Europe Enzalutamide API Revenue by Country (2018-2023)
7.2 Europe Enzalutamide API Sales by Type
7.3 Europe Enzalutamide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Enzalutamide API by Country
8.1.1 Middle East & Africa Enzalutamide API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Enzalutamide API Revenue by Country (2018-2023)
8.2 Middle East & Africa Enzalutamide API Sales by Type
8.3 Middle East & Africa Enzalutamide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enzalutamide API
10.3 Manufacturing Process Analysis of Enzalutamide API
10.4 Industry Chain Structure of Enzalutamide API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enzalutamide API Distributors
11.3 Enzalutamide API Customer
12 WORLD FORECAST REVIEW FOR ENZALUTAMIDE API BY GEOGRAPHIC REGION
12.1 Global Enzalutamide API Market Size Forecast by Region
12.1.1 Global Enzalutamide API Forecast by Region (2024-2029)
12.1.2 Global Enzalutamide API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enzalutamide API Forecast by Type
12.7 Global Enzalutamide API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy’s Laboratories Ltd.
13.1.1 Dr. Reddy’s Laboratories Ltd. Company Information
13.1.2 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product Portfolios and Specifications
13.1.3 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dr. Reddy’s Laboratories Ltd. Main Business Overview
13.1.5 Dr. Reddy’s Laboratories Ltd. Latest Developments
13.2 Shilpa Medicare Limited
13.2.1 Shilpa Medicare Limited Company Information
13.2.2 Shilpa Medicare Limited Enzalutamide API Product Portfolios and Specifications
13.2.3 Shilpa Medicare Limited Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shilpa Medicare Limited Main Business Overview
13.2.5 Shilpa Medicare Limited Latest Developments
13.3 ScinoPharm Taiwan, Ltd
13.3.1 ScinoPharm Taiwan, Ltd Company Information
13.3.2 ScinoPharm Taiwan, Ltd Enzalutamide API Product Portfolios and Specifications
13.3.3 ScinoPharm Taiwan, Ltd Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ScinoPharm Taiwan, Ltd Main Business Overview
13.3.5 ScinoPharm Taiwan, Ltd Latest Developments
13.4 Olon Spa
13.4.1 Olon Spa Company Information
13.4.2 Olon Spa Enzalutamide API Product Portfolios and Specifications
13.4.3 Olon Spa Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Olon Spa Main Business Overview
13.4.5 Olon Spa Latest Developments
13.5 Farmhispania, S.A.
13.5.1 Farmhispania, S.A. Company Information
13.5.2 Farmhispania, S.A. Enzalutamide API Product Portfolios and Specifications
13.5.3 Farmhispania, S.A. Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Farmhispania, S.A. Main Business Overview
13.5.5 Farmhispania, S.A. Latest Developments
13.6 Mac-Chem Products (India) Pvt.Ltd
13.6.1 Mac-Chem Products (India) Pvt.Ltd Company Information
13.6.2 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product Portfolios and Specifications
13.6.3 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mac-Chem Products (India) Pvt.Ltd Main Business Overview
13.6.5 Mac-Chem Products (India) Pvt.Ltd Latest Developments
13.7 Shandong Haohong Biotechnology
13.7.1 Shandong Haohong Biotechnology Company Information
13.7.2 Shandong Haohong Biotechnology Enzalutamide API Product Portfolios and Specifications
13.7.3 Shandong Haohong Biotechnology Enzalutamide API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shandong Haohong Biotechnology Main Business Overview
13.7.5 Shandong Haohong Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Enzalutamide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Enzalutamide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity?98%
Table 4. Major Players of Purity<98%
Table 5. Global Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 6. Global Enzalutamide API Sales Market Share by Type (2018-2023)
Table 7. Global Enzalutamide API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Enzalutamide API Revenue Market Share by Type (2018-2023)
Table 9. Global Enzalutamide API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 11. Global Enzalutamide API Sales Market Share by Application (2018-2023)
Table 12. Global Enzalutamide API Revenue by Application (2018-2023)
Table 13. Global Enzalutamide API Revenue Market Share by Application (2018-2023)
Table 14. Global Enzalutamide API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Enzalutamide API Sales by Company (2018-2023) & (Kiloton)
Table 16. Global Enzalutamide API Sales Market Share by Company (2018-2023)
Table 17. Global Enzalutamide API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Enzalutamide API Revenue Market Share by Company (2018-2023)
Table 19. Global Enzalutamide API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Enzalutamide API Producing Area Distribution and Sales Area
Table 21. Players Enzalutamide API Products Offered
Table 22. Enzalutamide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Enzalutamide API Sales by Geographic Region (2018-2023) & (Kiloton)
Table 26. Global Enzalutamide API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Enzalutamide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Enzalutamide API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Enzalutamide API Sales by Country/Region (2018-2023) & (Kiloton)
Table 30. Global Enzalutamide API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Enzalutamide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Enzalutamide API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Enzalutamide API Sales by Country (2018-2023) & (Kiloton)
Table 34. Americas Enzalutamide API Sales Market Share by Country (2018-2023)
Table 35. Americas Enzalutamide API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Enzalutamide API Revenue Market Share by Country (2018-2023)
Table 37. Americas Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 38. Americas Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 39. APAC Enzalutamide API Sales by Region (2018-2023) & (Kiloton)
Table 40. APAC Enzalutamide API Sales Market Share by Region (2018-2023)
Table 41. APAC Enzalutamide API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Enzalutamide API Revenue Market Share by Region (2018-2023)
Table 43. APAC Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 44. APAC Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 45. Europe Enzalutamide API Sales by Country (2018-2023) & (Kiloton)
Table 46. Europe Enzalutamide API Sales Market Share by Country (2018-2023)
Table 47. Europe Enzalutamide API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Enzalutamide API Revenue Market Share by Country (2018-2023)
Table 49. Europe Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 50. Europe Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 51. Middle East & Africa Enzalutamide API Sales by Country (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Enzalutamide API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Enzalutamide API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Enzalutamide API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 57. Key Market Drivers & Growth Opportunities of Enzalutamide API
Table 58. Key Market Challenges & Risks of Enzalutamide API
Table 59. Key Industry Trends of Enzalutamide API
Table 60. Enzalutamide API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Enzalutamide API Distributors List
Table 63. Enzalutamide API Customer List
Table 64. Global Enzalutamide API Sales Forecast by Region (2024-2029) & (Kiloton)
Table 65. Global Enzalutamide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Enzalutamide API Sales Forecast by Country (2024-2029) & (Kiloton)
Table 67. Americas Enzalutamide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Enzalutamide API Sales Forecast by Region (2024-2029) & (Kiloton)
Table 69. APAC Enzalutamide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Enzalutamide API Sales Forecast by Country (2024-2029) & (Kiloton)
Table 71. Europe Enzalutamide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Enzalutamide API Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Middle East & Africa Enzalutamide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Enzalutamide API Sales Forecast by Type (2024-2029) & (Kiloton)
Table 75. Global Enzalutamide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Enzalutamide API Sales Forecast by Application (2024-2029) & (Kiloton)
Table 77. Global Enzalutamide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Dr. Reddy’s Laboratories Ltd. Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 79. Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product Portfolios and Specifications
Table 80. Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Dr. Reddy’s Laboratories Ltd. Main Business
Table 82. Dr. Reddy’s Laboratories Ltd. Latest Developments
Table 83. Shilpa Medicare Limited Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 84. Shilpa Medicare Limited Enzalutamide API Product Portfolios and Specifications
Table 85. Shilpa Medicare Limited Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Shilpa Medicare Limited Main Business
Table 87. Shilpa Medicare Limited Latest Developments
Table 88. ScinoPharm Taiwan, Ltd Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 89. ScinoPharm Taiwan, Ltd Enzalutamide API Product Portfolios and Specifications
Table 90. ScinoPharm Taiwan, Ltd Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. ScinoPharm Taiwan, Ltd Main Business
Table 92. ScinoPharm Taiwan, Ltd Latest Developments
Table 93. Olon Spa Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 94. Olon Spa Enzalutamide API Product Portfolios and Specifications
Table 95. Olon Spa Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Olon Spa Main Business
Table 97. Olon Spa Latest Developments
Table 98. Farmhispania, S.A. Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 99. Farmhispania, S.A. Enzalutamide API Product Portfolios and Specifications
Table 100. Farmhispania, S.A. Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Farmhispania, S.A. Main Business
Table 102. Farmhispania, S.A. Latest Developments
Table 103. Mac-Chem Products (India) Pvt.Ltd Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 104. Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product Portfolios and Specifications
Table 105. Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Mac-Chem Products (India) Pvt.Ltd Main Business
Table 107. Mac-Chem Products (India) Pvt.Ltd Latest Developments
Table 108. Shandong Haohong Biotechnology Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 109. Shandong Haohong Biotechnology Enzalutamide API Product Portfolios and Specifications
Table 110. Shandong Haohong Biotechnology Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Shandong Haohong Biotechnology Main Business
Table 112. Shandong Haohong Biotechnology Latest Developments
Table 1. Enzalutamide API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Enzalutamide API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity?98%
Table 4. Major Players of Purity<98%
Table 5. Global Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 6. Global Enzalutamide API Sales Market Share by Type (2018-2023)
Table 7. Global Enzalutamide API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Enzalutamide API Revenue Market Share by Type (2018-2023)
Table 9. Global Enzalutamide API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 11. Global Enzalutamide API Sales Market Share by Application (2018-2023)
Table 12. Global Enzalutamide API Revenue by Application (2018-2023)
Table 13. Global Enzalutamide API Revenue Market Share by Application (2018-2023)
Table 14. Global Enzalutamide API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Enzalutamide API Sales by Company (2018-2023) & (Kiloton)
Table 16. Global Enzalutamide API Sales Market Share by Company (2018-2023)
Table 17. Global Enzalutamide API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Enzalutamide API Revenue Market Share by Company (2018-2023)
Table 19. Global Enzalutamide API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Enzalutamide API Producing Area Distribution and Sales Area
Table 21. Players Enzalutamide API Products Offered
Table 22. Enzalutamide API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Enzalutamide API Sales by Geographic Region (2018-2023) & (Kiloton)
Table 26. Global Enzalutamide API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Enzalutamide API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Enzalutamide API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Enzalutamide API Sales by Country/Region (2018-2023) & (Kiloton)
Table 30. Global Enzalutamide API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Enzalutamide API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Enzalutamide API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Enzalutamide API Sales by Country (2018-2023) & (Kiloton)
Table 34. Americas Enzalutamide API Sales Market Share by Country (2018-2023)
Table 35. Americas Enzalutamide API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Enzalutamide API Revenue Market Share by Country (2018-2023)
Table 37. Americas Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 38. Americas Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 39. APAC Enzalutamide API Sales by Region (2018-2023) & (Kiloton)
Table 40. APAC Enzalutamide API Sales Market Share by Region (2018-2023)
Table 41. APAC Enzalutamide API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Enzalutamide API Revenue Market Share by Region (2018-2023)
Table 43. APAC Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 44. APAC Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 45. Europe Enzalutamide API Sales by Country (2018-2023) & (Kiloton)
Table 46. Europe Enzalutamide API Sales Market Share by Country (2018-2023)
Table 47. Europe Enzalutamide API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Enzalutamide API Revenue Market Share by Country (2018-2023)
Table 49. Europe Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 50. Europe Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 51. Middle East & Africa Enzalutamide API Sales by Country (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Enzalutamide API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Enzalutamide API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Enzalutamide API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Enzalutamide API Sales by Type (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Enzalutamide API Sales by Application (2018-2023) & (Kiloton)
Table 57. Key Market Drivers & Growth Opportunities of Enzalutamide API
Table 58. Key Market Challenges & Risks of Enzalutamide API
Table 59. Key Industry Trends of Enzalutamide API
Table 60. Enzalutamide API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Enzalutamide API Distributors List
Table 63. Enzalutamide API Customer List
Table 64. Global Enzalutamide API Sales Forecast by Region (2024-2029) & (Kiloton)
Table 65. Global Enzalutamide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Enzalutamide API Sales Forecast by Country (2024-2029) & (Kiloton)
Table 67. Americas Enzalutamide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Enzalutamide API Sales Forecast by Region (2024-2029) & (Kiloton)
Table 69. APAC Enzalutamide API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Enzalutamide API Sales Forecast by Country (2024-2029) & (Kiloton)
Table 71. Europe Enzalutamide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Enzalutamide API Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Middle East & Africa Enzalutamide API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Enzalutamide API Sales Forecast by Type (2024-2029) & (Kiloton)
Table 75. Global Enzalutamide API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Enzalutamide API Sales Forecast by Application (2024-2029) & (Kiloton)
Table 77. Global Enzalutamide API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Dr. Reddy’s Laboratories Ltd. Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 79. Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product Portfolios and Specifications
Table 80. Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Dr. Reddy’s Laboratories Ltd. Main Business
Table 82. Dr. Reddy’s Laboratories Ltd. Latest Developments
Table 83. Shilpa Medicare Limited Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 84. Shilpa Medicare Limited Enzalutamide API Product Portfolios and Specifications
Table 85. Shilpa Medicare Limited Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Shilpa Medicare Limited Main Business
Table 87. Shilpa Medicare Limited Latest Developments
Table 88. ScinoPharm Taiwan, Ltd Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 89. ScinoPharm Taiwan, Ltd Enzalutamide API Product Portfolios and Specifications
Table 90. ScinoPharm Taiwan, Ltd Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. ScinoPharm Taiwan, Ltd Main Business
Table 92. ScinoPharm Taiwan, Ltd Latest Developments
Table 93. Olon Spa Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 94. Olon Spa Enzalutamide API Product Portfolios and Specifications
Table 95. Olon Spa Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Olon Spa Main Business
Table 97. Olon Spa Latest Developments
Table 98. Farmhispania, S.A. Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 99. Farmhispania, S.A. Enzalutamide API Product Portfolios and Specifications
Table 100. Farmhispania, S.A. Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Farmhispania, S.A. Main Business
Table 102. Farmhispania, S.A. Latest Developments
Table 103. Mac-Chem Products (India) Pvt.Ltd Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 104. Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product Portfolios and Specifications
Table 105. Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Mac-Chem Products (India) Pvt.Ltd Main Business
Table 107. Mac-Chem Products (India) Pvt.Ltd Latest Developments
Table 108. Shandong Haohong Biotechnology Basic Information, Enzalutamide API Manufacturing Base, Sales Area and Its Competitors
Table 109. Shandong Haohong Biotechnology Enzalutamide API Product Portfolios and Specifications
Table 110. Shandong Haohong Biotechnology Enzalutamide API Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Shandong Haohong Biotechnology Main Business
Table 112. Shandong Haohong Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Enzalutamide API
Figure 2. Enzalutamide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enzalutamide API Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Enzalutamide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Enzalutamide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity?98%
Figure 10. Product Picture of Purity<98%
Figure 11. Global Enzalutamide API Sales Market Share by Type in 2022
Figure 12. Global Enzalutamide API Revenue Market Share by Type (2018-2023)
Figure 13. Enzalutamide API Consumed in Enzalutamide Capsules
Figure 14. Global Enzalutamide API Market: Enzalutamide Capsules (2018-2023) & (Kiloton)
Figure 15. Enzalutamide API Consumed in Others
Figure 16. Global Enzalutamide API Market: Others (2018-2023) & (Kiloton)
Figure 17. Global Enzalutamide API Sales Market Share by Application (2022)
Figure 18. Global Enzalutamide API Revenue Market Share by Application in 2022
Figure 19. Enzalutamide API Sales Market by Company in 2022 (Kiloton)
Figure 20. Global Enzalutamide API Sales Market Share by Company in 2022
Figure 21. Enzalutamide API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Enzalutamide API Revenue Market Share by Company in 2022
Figure 23. Global Enzalutamide API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Enzalutamide API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Enzalutamide API Sales 2018-2023 (Kiloton)
Figure 26. Americas Enzalutamide API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Enzalutamide API Sales 2018-2023 (Kiloton)
Figure 28. APAC Enzalutamide API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Enzalutamide API Sales 2018-2023 (Kiloton)
Figure 30. Europe Enzalutamide API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Enzalutamide API Sales 2018-2023 (Kiloton)
Figure 32. Middle East & Africa Enzalutamide API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Enzalutamide API Sales Market Share by Country in 2022
Figure 34. Americas Enzalutamide API Revenue Market Share by Country in 2022
Figure 35. Americas Enzalutamide API Sales Market Share by Type (2018-2023)
Figure 36. Americas Enzalutamide API Sales Market Share by Application (2018-2023)
Figure 37. United States Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Enzalutamide API Sales Market Share by Region in 2022
Figure 42. APAC Enzalutamide API Revenue Market Share by Regions in 2022
Figure 43. APAC Enzalutamide API Sales Market Share by Type (2018-2023)
Figure 44. APAC Enzalutamide API Sales Market Share by Application (2018-2023)
Figure 45. China Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Enzalutamide API Sales Market Share by Country in 2022
Figure 53. Europe Enzalutamide API Revenue Market Share by Country in 2022
Figure 54. Europe Enzalutamide API Sales Market Share by Type (2018-2023)
Figure 55. Europe Enzalutamide API Sales Market Share by Application (2018-2023)
Figure 56. Germany Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Enzalutamide API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Enzalutamide API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Enzalutamide API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Enzalutamide API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Enzalutamide API in 2022
Figure 71. Manufacturing Process Analysis of Enzalutamide API
Figure 72. Industry Chain Structure of Enzalutamide API
Figure 73. Channels of Distribution
Figure 74. Global Enzalutamide API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Enzalutamide API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Enzalutamide API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Enzalutamide API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Enzalutamide API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Enzalutamide API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Enzalutamide API
Figure 2. Enzalutamide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enzalutamide API Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Enzalutamide API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Enzalutamide API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity?98%
Figure 10. Product Picture of Purity<98%
Figure 11. Global Enzalutamide API Sales Market Share by Type in 2022
Figure 12. Global Enzalutamide API Revenue Market Share by Type (2018-2023)
Figure 13. Enzalutamide API Consumed in Enzalutamide Capsules
Figure 14. Global Enzalutamide API Market: Enzalutamide Capsules (2018-2023) & (Kiloton)
Figure 15. Enzalutamide API Consumed in Others
Figure 16. Global Enzalutamide API Market: Others (2018-2023) & (Kiloton)
Figure 17. Global Enzalutamide API Sales Market Share by Application (2022)
Figure 18. Global Enzalutamide API Revenue Market Share by Application in 2022
Figure 19. Enzalutamide API Sales Market by Company in 2022 (Kiloton)
Figure 20. Global Enzalutamide API Sales Market Share by Company in 2022
Figure 21. Enzalutamide API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Enzalutamide API Revenue Market Share by Company in 2022
Figure 23. Global Enzalutamide API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Enzalutamide API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Enzalutamide API Sales 2018-2023 (Kiloton)
Figure 26. Americas Enzalutamide API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Enzalutamide API Sales 2018-2023 (Kiloton)
Figure 28. APAC Enzalutamide API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Enzalutamide API Sales 2018-2023 (Kiloton)
Figure 30. Europe Enzalutamide API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Enzalutamide API Sales 2018-2023 (Kiloton)
Figure 32. Middle East & Africa Enzalutamide API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Enzalutamide API Sales Market Share by Country in 2022
Figure 34. Americas Enzalutamide API Revenue Market Share by Country in 2022
Figure 35. Americas Enzalutamide API Sales Market Share by Type (2018-2023)
Figure 36. Americas Enzalutamide API Sales Market Share by Application (2018-2023)
Figure 37. United States Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Enzalutamide API Sales Market Share by Region in 2022
Figure 42. APAC Enzalutamide API Revenue Market Share by Regions in 2022
Figure 43. APAC Enzalutamide API Sales Market Share by Type (2018-2023)
Figure 44. APAC Enzalutamide API Sales Market Share by Application (2018-2023)
Figure 45. China Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Enzalutamide API Sales Market Share by Country in 2022
Figure 53. Europe Enzalutamide API Revenue Market Share by Country in 2022
Figure 54. Europe Enzalutamide API Sales Market Share by Type (2018-2023)
Figure 55. Europe Enzalutamide API Sales Market Share by Application (2018-2023)
Figure 56. Germany Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Enzalutamide API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Enzalutamide API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Enzalutamide API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Enzalutamide API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Enzalutamide API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Enzalutamide API in 2022
Figure 71. Manufacturing Process Analysis of Enzalutamide API
Figure 72. Industry Chain Structure of Enzalutamide API
Figure 73. Channels of Distribution
Figure 74. Global Enzalutamide API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Enzalutamide API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Enzalutamide API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Enzalutamide API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Enzalutamide API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Enzalutamide API Revenue Market Share Forecast by Application (2024-2029)
